Back to top
more

PRA Health Sciences, Inc. (PRAH)

(Delayed Data from NSDQ)

$93.38 USD

93.38
1,010,066

+1.38 (1.50%)

Updated May 3, 2019 04:00 PM ET

After-Market: $93.43 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Teladoc (TDOC) Up 26% in 22 Days, Will Upside Continue?

by Zacks Equity Research

Teladoc (TDOC) shares gain on strong operating performance in second quarter.

    Teladoc (TDOC) Hits 52-Week High, Will the Rally Continue?

    by Zacks Equity Research

    Strong second-quarter earnings performance and favorable guidance pulled up the stock of Teladoc (TDOC).

      PRA Health's (PRAH) Q2 Earnings Top, Revenues Lag Estimates

      by Zacks Equity Research

      PRA Health (PRAH) sees year-over-year double-digit growth in earnings, revenues and net new business in Q2. However, increasing labor-related costs in the Clinical Research wing is a concern.

        Is a Surprise Coming for PRA Health Sciences (PRAH) This Earnings Season?

        by Zacks Equity Research

        PRA Health Sciences (PRAH) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

          Will Revenue, Membership Growth Aid Cigna (CI) Q2 Earnings?

          by Zacks Equity Research

          Cigna (CI) Q2 earnings is likely to gain from strong growth at its segments.

            Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?

            by Zacks Equity Research

            Aetna (AET) Q2 earnings to suffer from lower membership and revenues partly offset by a lower tax rate.

              Will Revenue Growth Drive Teladoc (TDOC) Q2 Earnings Higher?

              by Zacks Equity Research

              Teladoc (TDOC) Q2 earnings to gain from increased patient visits and subscription fees.

                Acquisitions Aid Revenue Growth at Ensign Group (ENSG)

                by Zacks Equity Research

                Ensign Group's (ENSG) acquisitions over several past years have driven growth.

                  Zacks.com highlights: Blucora, Roper Technologies, PRA Health Sciences, M.D.C. Holdings and Cleveland-Cliffs

                  by Zacks Equity Research

                  Zacks.com highlights: Blucora, Roper Technologies, PRA Health Sciences, M.D.C. Holdings and Cleveland-Cliffs

                    Kevin Matras headshot

                    Winning Stock Picks from the Top 5 Industries with the Biggest Job Growth

                    by Kevin Matras

                    Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include BCOR, ROP, PRAH, MDC and CLF.

                      Pra Health Grows Organically, Symphony Synergies a Positive

                      by Zacks Equity Research

                      The $530-million Symphony buyout buoys hope for PRA Health (PRAH). The move is likely to improve its ability in the clinical research and commercial development process via data and analytics tools.

                        PRA Health (PRAH) Up 0.2% in a Month Post Mixed Q1 Earnings

                        by Zacks Equity Research

                        PRA Health's (PRAH) shares gain from better-than-expected Q1 earnings. However, increasing labor-related costs in the Clinical Research wing is a headwind.

                          Healthcare Stock Q1 Earnings Due on Apr 25: ANTM, UHS, PRAH

                          by Zacks Equity Research

                          Severe flu activity in the first quarter should benefit companies in the health care space, while insurers might feel the pinch from the same.

                            New Year to Bring Back MedTech Tax, 3 Stocks Unfazed

                            by Zacks Equity Research

                            Investors are apprehensive about the re-enactment of MedTech Tax and related concerns, despite raking in returns from other sectors.

                              PRA Health (PRAH) Hits 52-Week High on Multiple Positives

                              by Zacks Equity Research

                              PRA Health (PRAH) touches 52-week high on consistent revenue performance and Symphony Health integration.

                                Here's Why You Should Steer Clear of LifePoint (LPNT) Stock

                                by Zacks Equity Research

                                LifePoint (LPNT) continues to suffer due to a challenging volume environment and weak revenues.

                                  The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

                                  by Zacks Equity Research

                                  The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

                                    4 Attractive Stocks to Buy in an Evolving Healthcare Space

                                    by Zacks Equity Research

                                    The evolving healthcare industry presents an attractive buying opportunity for investors.

                                      Why Intrexon (XON) Could Be Positioned for a Slump

                                      by Zacks Equity Research

                                      Investors may consider dropping Intrexon (XON) stock that has seen both price depreciation as well as downward estimate revision in the past one month.

                                        Express Scripts (ESRX) Looks Good: Stock Adds 5.8% in Session

                                        by Zacks Equity Research

                                        Express Scripts (ESRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

                                          HCA Healthcare (HCA) Surges: Stock Moves 6.1% Higher

                                          by Zacks Equity Research

                                          HCA Healthcare (HCA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

                                            Teladoc Rides on Growing Demand for Telehealth Services

                                            by Zacks Equity Research

                                            Rising demand for telehealth services is likely to create long-term growth opportunities for Teladoc's (TDOC).

                                              Intrexon (XON) in Focus: Stock Moves 6.5% Higher

                                              by Zacks Equity Research

                                              Intrexon (XON) shares rose nearly 7% in the last trading session, amid huge volumes.

                                                Zacks.com featured highlights PRA Health Sciences, Align Technology, Adobe Systems and Par Pacific Holdings

                                                by Zacks Equity Research

                                                Zacks.com featured highlights PRA Health Sciences, Align Technology, Adobe Systems and Par Pacific Holdings

                                                  Buy These 4 Top-Ranked Profitable Stocks in November

                                                  by Zacks Equity Research

                                                  A profitable company is able to meet all its operating costs and offer stupendous returns to its investors.